Review: taking Lortab and Tagamet hb together


Summary

Drug interactions are reported among people who take Lortab and Tagamet hb together. This review analyzes the effectiveness and drug interactions between Lortab and Tagamet hb. It is created by eHealthMe based on reports of 727 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Lortab

Lortab has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. (latest outcomes from Lortab 22,327 users)

Tagamet Hb

Tagamet hb has active ingredients of cimetidine. It is often used in indigestion. (latest outcomes from Tagamet hb 508 users)

On Sep, 19, 2016

727 people who take Lortab, Tagamet Hb are studied.


Number of reports submitted per year:

Lortab and Tagamet hb drug interactions.

Drug effectiveness over time:

Lortab:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 100.0% - (2 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Tagamet Hb:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 2 people)
  • 2 - 5 years: 100.0% - (2 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Lortab:
  • female: 75.0% - (3 of 4 people)
  • male: 50.0% - (1 of 2 people)
Tagamet Hb:
  • female: 40.0% - (2 of 5 people)
  • male: 50.0% - (1 of 2 people)

Drug effectiveness by age:

Lortab:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 100.0% - (1 of 1 people)
Tagamet Hb:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 66.0% - (2 of 3 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 100.0% - (1 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • fall
  • back pain
  • pain in extremity
  • dyspnoea
  • suicidal ideation
  • asthenia
  • contusion
  • fatigue
  • hyperhidrosis
  • joint injury
1 - 6 months:
  • anaemia
  • convulsion
  • fungal sepsis
  • hypokalaemia
  • hypomagnesaemia
  • infection
  • malignant neoplasm progression
  • neutropenia
  • neutropenic sepsis
  • pericardial effusion
6 - 12 months:
  • anxiety disorder
  • arthralgia
  • arthritis
  • back pain
  • bone density decreased
  • bone disorder
  • chronic obstructive pulmonary disease
  • crohn's disease
  • depression
  • diabetes mellitus
1 - 2 years:
  • anterograde amnesia
  • dry mouth
  • dysmenorrhoea
  • gynaecomastia
  • menorrhagia
2 - 5 years:
  • short-term memory loss
  • stuttering
  • dizziness
  • facial tics
  • fatigue
  • tardive dyskinesia
  • alanine aminotransferase increased
  • ankle fracture
  • aspartate aminotransferase increased
  • back disorder
5 - 10 years:
  • ankle fracture
  • arthritis
  • asthenia
  • back disorder
  • bone disorder
  • breast mass
  • fall
  • foot fracture
  • gynaecomastia
  • headache
10+ years:
  • po2 increased
  • weight gain poor
  • arthritis
  • bone disorder
  • calcium deficiency
  • intervertebral disc protrusion
  • osteopenia
  • osteoporosis
  • vitamin d deficiency
  • anxiety
not specified:
  • pain
  • nausea
  • fatigue
  • anxiety
  • vomiting
  • back pain
  • dyspnoea
  • bone disorder
  • fall
  • anaemia

Most common drug interactions by gender *:

female:
  • pain
  • anaemia
  • nausea
  • fatigue
  • back pain
  • osteoporosis
  • osteomyelitis
  • osteoarthritis
  • swelling
  • fall
male:
  • pain
  • dyspnoea
  • nausea
  • fatigue
  • chest pain
  • anxiety
  • vomiting
  • asthenia
  • back pain
  • bone disorder

Most common drug interactions by age *:

10-19:
  • pain
  • biliary dyskinesia
  • cholecystitis chronic
  • cholelithiasis
  • constipation
  • diarrhoea
  • injury
  • vomiting
  • abdominal pain lower
  • abdominal pain upper
20-29:
  • vomiting
  • back pain
  • constipation
  • nausea
  • pain
  • anxiety
  • chest pain
  • dyspnoea
  • general physical health deterioration
  • lethargy
30-39:
  • nausea
  • fatigue
  • headache
  • pancytopenia
  • heart rate increased
  • colitis pseudomembranous
  • neutropenia
  • chest pain
  • depression
  • dyspnoea
40-49:
  • fatigue
  • nausea
  • back pain
  • asthenia
  • pain
  • intervertebral disc protrusion
  • anxiety
  • chest pain
  • vomiting
  • fall
50-59:
  • pain
  • anaemia
  • nausea
  • bone disorder
  • oedema peripheral
  • diarrhoea
  • osteoarthritis
  • swelling
  • pain in jaw
  • osteoporosis
60+:
  • dyspnoea
  • pain
  • chest pain
  • osteonecrosis of jaw
  • constipation
  • rectal haemorrhage
  • osteoporosis
  • fatigue
  • anxiety
  • arthritis

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Lortab and Tagamet hb?

You may be interested in these reviews

More reviews for: Lortab, Tagamet hb

On eHealthMe, Lortab (acetaminophen; hydrocodone bitartrate) is often used to treat pain. Tagamet hb (cimetidine) is often used to treat indigestion. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.